Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton

By sjmartinez • June 28, 2023

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna J, Rozengurt E. Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton. Am J Physiol Gastrointest Liver Physiol. 2023 Jun 27. doi: 10.1152/ajpgi.00089.2023. Epub ahead of print. PMID: 37366601.

Tags: chemoprevention, Digestive Diseases, Hepatocellular carcinoma, Publications, Statins, Veterans Administration, YAP

Authors’ Reply on Immune-Mediated Liver Injury in HCC

Ennin E, Mallepally N, Dodge JL, Dara L. Authors' Reply on Immune-Mediated Liver Injury in HCC. Liver Int. 2025 Nov;45(11):e70415. doi: 10.1111/liv.70415. PMID: 41122960.

Changes in Colorectal Cancer Screening Modalities Among Insured Individuals

Siddique S, Wang R, May FP, Baum LVM, Gross CP, Ma X. Changes in Colorectal Cancer Screening Modalities Among Insured Individuals. JAMA Netw Open. 2025[...]

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

Singh S, Murad MH, Yuan Y, Ananthakrishnan AN, Click B, Syal G, Haydek JP, Agrawal M, Kappelman MD, Lewis JD, Scott FI. Comparative Efficacy of[...]